Z A Shaikh

Author PubWeight™ 49.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001 1.64
2 Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 1999 1.59
3 Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000 1.54
4 MRI findings in 32 consecutive lipomas using conventional and advanced sequences. J Neuroimaging 1999 1.48
5 Isolation of cadmium-binding proteins. Experientia 1971 1.30
6 The biosynthesis of metallothionein rat liver and kidney after administration of cadmium. Chem Biol Interact 1976 1.17
7 Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000 1.15
8 Metabolism of intravenously injected cadmium-binding protein. Biochem Biophys Res Commun 1975 1.10
9 Cadmium and zinc binding in mammalian liver and kidneys. Arch Environ Health 1972 1.08
10 Cadmium and zinc in pregnancy and lactation. Arch Environ Health 1972 1.02
11 MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000 0.99
12 Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology 1992 0.97
13 Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 1999 0.97
14 The vascular endothelium as a target tissue in acute cadmium toxicity. Life Sci 1986 0.97
15 Elevated urinary excretion of metallothionein due to environmental cadmium exposure. Toxicology 1981 0.93
16 Metallothionein in the extracellular fluids as an index of cadmium toxicity. Environ Health Perspect 1979 0.93
17 Differences in cadmium and mercury uptakes by hepatocytes: role of calcium channels. Toxicol Appl Pharmacol 1991 0.93
18 Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay. Fundam Appl Toxicol 1983 0.92
19 Cytotoxicity of cadmium and characteristics of its transport in cardiomyocytes. Toxicol Appl Pharmacol 1999 0.92
20 Sex differences in hepatic and renal cadmium accumulation and metallothionein induction. Role of estradiol. Biochem Pharmacol 1991 0.91
21 The mechanisms of hepatic and renal metallothionein biosynthesis in cadmium-exposed rats. Chem Biol Interact 1977 0.90
22 Cadmium uptake by primary cultures of rat renal cortical epithelial cells: influence of cell density and other metal ions. Toxicol Appl Pharmacol 1993 0.89
23 Biological differences in cadmium and zinc turnover. Arch Environ Health 1972 0.87
24 Metallothionein excretion in urine upon cadmium exposure: its relationship with liver and kidney cadmium. Toxicology 1981 0.87
25 Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc. Toxicology 1983 0.86
26 Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione. Toxicol Appl Pharmacol 1998 0.86
27 Metallothionein as a storage protein for cadmium: its toxicological implications. Dev Toxicol Environ Sci 1982 0.85
28 Cross-reactivity of metallothioneins from different origins with rabbit anti-rat hepatic metallothione in antibody. Biochem Biophys Res Commun 1978 0.84
29 Occupational exposure to cadmium: effect on metallothionein and other biological indices of exposure and renal function. Arch Toxicol 1987 0.82
30 Cadmium and mercury accumulation in rat hepatocytes: interactions with other metal ions. Toxicol Appl Pharmacol 1992 0.82
31 Uptake and binding of cadmium and mercury to metallothionein in rat hepatocyte primary cultures. Biochem J 1982 0.81
32 Renal cortical mitochondrial dysfunction upon cadmium metallothionein administration to Sprague-Dawley rats. J Toxicol Environ Health A 2001 0.81
33 Urinary metallothionein as a new index of renal dysfunction in "Itai-Itai" disease patients and other Japanese women environmentally exposed to cadmium. Arch Toxicol 1982 0.81
34 Decreased uptake and altered subcellular disposition of testicular cadmium as possible mechanisms of resistance to cadmium-induced testicular necrosis in inbred mice. Toxicology 1984 0.80
35 An evaluation of tissue metallothionein and genetic resistance to cadmium toxicity in mice. Toxicol Appl Pharmacol 1986 0.80
36 Dose-response relationship between urinary cadmium and metallothionein in a Japanese population environmentally exposed to cadmium. Toxicology 1991 0.79
37 Dose-response relationship between dietary cadmium intake and metallothioneinuria in a population from a cadmium-polluted area of Japan. Toxicology 1991 0.79
38 Cadmium as a trace element and cadmium binding components in human cells. Experientia 1970 0.79
39 Urinary metallothionein as an indicator of cadmium body burden and of cadmium-induced nephrotoxicity. Environ Health Perspect 1984 0.79
40 Dose-response relationship between total cadmium intake and metallothioneinuria using logistic regression analysis. Toxicology 1993 0.79
41 Early-onset Moyamoya syndrome in a patient with Down syndrome: case report and review of the literature. J Child Neurol 2000 0.79
42 Developmental and sex differences in cadmium distribution and metallothionein induction and localization. J Appl Toxicol 1988 0.78
43 Dose-response relationship between total cadmium intake and prevalence of renal dysfunction using general linear models. J Appl Toxicol 1995 0.78
44 Determination of metallothionein in tissues by radioimmunoassay and by cadmium saturation method. Anal Biochem 1986 0.78
45 Biological indicators of cadmium exposure and toxicity. Experientia Suppl 1986 0.78
46 Application of path analysis to urinary findings of cadmium-induced renal dysfunction. J Environ Sci Health A Tox Hazard Subst Environ Eng 2001 0.78
47 Resistance to cadmium-induced necrosis in testes of inbred mice: possible role of a metallothionein-like cadmium-binding protein. Toxicol Appl Pharmacol 1985 0.77
48 Measurement of cadmium-induced metallothionein in urine by ELISA and prevention of overestimation due to polymerization. J Anal Toxicol 1999 0.77
49 Radioimmunoassay for metallothionein in body fluids and tissues. Methods Enzymol 1991 0.77
50 Dose-effect relationship between ethyl alcohol pretreatment and retention and tissue distribution of mercury vapor in rats. J Pharmacol Exp Ther 1982 0.77
51 The low molecular weight cadmium-, mercury- and zinc-binding proteins (metallothioneins): biosynthesis, metabolism, and possible role in metal toxicity. Experientia Suppl 1979 0.77
52 Differences in the uptake of cadmium and mercury by rat hepatocyte primary cultures. Role of a sulfhydryl carrier. Biochem Pharmacol 1984 0.76
53 Metabolism of orally ingested cadmium in humans. Dev Toxicol Environ Sci 1980 0.76
54 The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol 1994 0.76
55 Comparison of cadmium, mercury and calcium accumulations by isolated hepatocytes of the small skate (Raja erinacea) and rat. Comp Biochem Physiol C 1992 0.75
56 Induction of metallothionein in rat tissues following subchronic exposure to mercury shown by radioimmunoassay. Biol Trace Elem Res 1987 0.75
57 Biological indicators of cadmium exposure and toxicity. Experientia 1984 0.75
58 Mercury uptake by LLC-PK1 cells: dependence on temperature and membrane potential. Toxicol Appl Pharmacol 1997 0.75
59 Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. III. Minimal battery of tests to assess subclinical nephrotoxicity for epidemiological studies based on current knowledge. Ren Fail 1997 0.75
60 Mercury uptake by primary cultures of rat renal cortical epithelial cells. I. Effects of cell density, temperature, and metabolic inhibitors. Toxicol Appl Pharmacol 1995 0.75
61 Subchronic treatment of rats with aurothioglucose; effects on plasma, hepatic, renal and urinary zinc, copper and metallothionein. Toxicology 1987 0.75
62 Mercury uptake by primary cultures of rat renal cortical epithelial cells. II. Effects of pH, halide ions, and alkali metal ions. Toxicol Appl Pharmacol 1995 0.75
63 Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium. IARC Sci Publ 1992 0.75